UASt regulatory sequences drive expression of an inverted repeat.
DCTN2-p50 silencing in segmental nerves of L3 larvae (DCTN2-p50GD13758, Scer\GAL4D42) significantly reduces the rate of mitochondria transported in the retrograde direction, but has no effect on retrograde speed or anterograde speed/rate.
DCTN2-p50 silencing (DCTN2-p50GD13758, Scer\GAL4elav-C155) does not result in any obvious changes to the microtubule network in larval segmental nerves.
Scer\GAL4elav-C155-mediated expression of DCTN2-p50GD13758 has no apparent effect on larval motor coordination or locomotion, or on eclosion rates.
Expression under the control of Scer\GAL41407 results in loss of neuroblasts in the larval brain associated with decreased size of the remaining neuroblasts.
Expression under the control of Scer\GAL41407 results in a reduction in the average size of neuroblasts together with shorter neuroblast lineages (less daughter cells per neuroblast) in the larval brain compared to controls.
Adults expressing DCTN2-p50GD13758 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Expression of DCTN2-p50GD13758 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) results in viable flies or partial lethality, depending on the particular P{GD13758} insertion line used.
DCTN2-p50GD13758, Scer\GAL4GMR.PF is an enhancer of eye phenotype of Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF
DCTN2-p50GD13758, Scer\GAL4elav-C155 is a non-enhancer of neuromuscular junction | larval stage phenotype of Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155
DCTN2-p50GD13758, Scer\GAL4GMR.PF is a non-enhancer of eye phenotype of Hsap\ATXN3tr.Q78.UAS.Tag:HA, Scer\GAL4GMR.PF
DCTN2-p50GD13758, Scer\GAL4GMR.PF is a non-suppressor of eye phenotype of Hsap\ATXN3tr.Q78.UAS.Tag:HA, Scer\GAL4GMR.PF
DCTN2-p50GD13758, Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has axon | larval stage phenotype
DCTN2-p50 silencing (DCTN2-p50GD13758, Scer\GAL4elav-C155) in combination with Hsap\MAPTR406W.Scer\UAS expression does not result in any obvious changes to the microtubule network in larval segmental nerves.
Scer\GAL4elav-C155-mediated expression of Hsap\MAPTR406W.Scer\UAS in combination with silencing of DCTN1-p150 (DCTN1-p150GD1455) or DCTN2-p50 (DCTN2-p50GD13758) results in axonal swellings in larval segmental nerves.
Scer\GAL4elav-C155-mediated co-expression of Hsap\MAPTR406W.Scer\UAS and DCTN2-p50GD13758 has no apparent effect on larval motor coordination or locomotion.
Scer\GAL4elav-C155-mediated co-expression of Hsap\MAPTR406W.Scer\UAS with DCTN2-p50GD13758 strongly reduces eclosion rates.
Scer\GAL4D42-mediated co-expression of Hsap\MAPTR406W.Scer\UAS with DCTN2-p50GD13758 has no impact on viability but an age-dependent decline in locomotion skills is observed.